Connective tissue diseases Flashcards
connective tissue diseases - general management
dependent on disease activity
- immune suppression
analgesic NSAIDs for joint/muscle symptoms
immune modulating treatment
- hydroxychloroquine
- methotrexate
- azathioprine
- mycophenolate
- biologic medication - cytokine inhibitors and lymphocyte depleting drugs
systemic steroids - prednisolone
Antibodies in autoimmune diseases
Anti-nuclear antibody (ANA)
Anti-double0strand DNA (dsDNA)
Anti-Ro antibody (Ro)
Anti-La antibody (La)
Anti-Centrmere antibody
Anti-Scl-70 antibody
Anti-neutrophil cytoplasmic antibody (ANCA)
Circulating immune complexes in Systemic Lupus Erythematosis
- ANA, ds,DNA and Ro
Systemic Lupus Erythematosis features
12-64/100,000 population
twins 20-50% concordance
females of child bearing age
photosensitivity common
- butterfly zygomatic rash
Systemic lupus Erythematosis - dental aspects
chronic anaemia
- oral ulceration
- GA risk
bleeding tendency
- thrombocytopenia
renal disease
- impaired drug metabolism
drug reactions -photosensitivity
steroid and immunosuppressive therapy
- possible increased malignancy risk
- lichenoid oral reactions
- oral pigmentation from hydroxyclorquine use
Sjogren’s syndrome features
inflammatory disease
- associated with circulating antibodies
- ANA, Ro and La
mainly associated with dry eyes and dry mouth
multi-system in some
- major salivary gland involvement
types of Sjorgren’s syndrome
Sicca syndrome
- dry eyes or dry mouth
primary Sjorgens
- not associated with any other disease
secondary Sjorgens
- associated with another connective tissue disease - e.g. rheumatoid arthritis, SLE
sjogrens syndrome oral and dental implications
oral infection
caries risk
functional loss
denture retention
swelling of salivary glands - sialois
Systemic sclerosis features
excessive collagen deposition
connective tissue fibrosis
loss of elastic tissue
predominantly effects women
gradual onset
slow progression - no treatment to prevent
Systemic sclerosis dental aspects
involvement of personal tissues
- limited mouth opening
- progressively poor oral access
- limited tongue movement
plan treatment 10 years ahead
dysphagia
reflux oesophagitis
- dental erosion
cardiac and renal vasculitic disease
- watch drug metabolism
widening of pdl space
- no dental mobility
Vasculitis features
inflammation of blood vessels
infarction of tissue
- may present as ulcers (tissue necrosis)
- may present as oral inflammatory masses
vessel wall thickens with inflammation
- narrowing of lumen
- reduced blood flow